ロード中...
Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Research Foundation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3342006/ https://ncbi.nlm.nih.gov/pubmed/22566956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2012.00075 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|